2xyw: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2xyw.png|left|200px]] | [[Image:2xyw.png|left|200px]] | ||
{{STRUCTURE_2xyw| PDB=2xyw | SCENE= }} | {{STRUCTURE_2xyw| PDB=2xyw | SCENE= }} | ||
===NOVEL SULFONYLTHIADIAZOLES WITH AN UNUSUAL BINDING MODE AS PARTIAL DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) GAMMA-DELTA AGONISTS WITH HIGH POTENCY AND IN-VIVO EFFICACY=== | ===NOVEL SULFONYLTHIADIAZOLES WITH AN UNUSUAL BINDING MODE AS PARTIAL DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) GAMMA-DELTA AGONISTS WITH HIGH POTENCY AND IN-VIVO EFFICACY=== | ||
{{ABSTRACT_PUBMED_21400663}} | {{ABSTRACT_PUBMED_21400663}} | ||
| Line 22: | Line 11: | ||
==See Also== | ==See Also== | ||
*[[Peroxisome Proliferator-Activated Receptors]] | *[[Peroxisome Proliferator-Activated Receptors|Peroxisome Proliferator-Activated Receptors]] | ||
==Reference== | ==Reference== | ||
| Line 29: | Line 18: | ||
[[Category: Marquette, J P.]] | [[Category: Marquette, J P.]] | ||
[[Category: Mathieu, M.]] | [[Category: Mathieu, M.]] | ||
[[Category: Activator]] | |||
[[Category: Dna-binding]] | |||
[[Category: Receptor]] | |||
[[Category: Transcription]] | |||
[[Category: Transcription regulation]] | |||
[[Category: Zinc-finger]] | |||
Revision as of 20:35, 25 July 2012
NOVEL SULFONYLTHIADIAZOLES WITH AN UNUSUAL BINDING MODE AS PARTIAL DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) GAMMA-DELTA AGONISTS WITH HIGH POTENCY AND IN-VIVO EFFICACY
Template:ABSTRACT PUBMED 21400663
About this Structure
2xyw is a 2 chain structure of Peroxisome Proliferator-Activated Receptors with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Keil S, Matter H, Schonafinger K, Glien M, Mathieu M, Marquette JP, Michot N, Haag-Diergarten S, Urmann M, Wendler W. Sulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (PPAR) gamma/delta agonists with high potency and in vivo efficacy. ChemMedChem. 2011 Apr 4;6(4):633-53. doi: 10.1002/cmdc.201100047. Epub, 2011 Mar 11. PMID:21400663 doi:10.1002/cmdc.201100047